美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

基因編輯

390.07

+3.881.01%

漲家數：5

跌家數：1

平家數：- -

市盈率：- -

高：395.96

開：386.50

低：378.08

收：386.19

資料載入中...

BUZZ-Intellia Therapeutics 第四季度合作收入好於預期，業績大幅增長

Sangamo Therapeutics, Inc.盤中異動股價大漲5.21%報1.030美元

Crispr Therapeutics Ag盤中異動股價大漲5.03%

Editas Medicine, Inc.盤中異動早盤大幅上漲5.43%報1.94美元

Intellia Therapeutics, Inc.盤中異動早盤大幅上漲5.60%

Beam Therapeutics Inc.盤中異動大幅下跌5.06%報28.33美元

Crispr Therapeutics Ag盤中異動下午盤急速下跌5.00%報44.24美元

Sangamo Therapeutics, Inc.盤中異動臨近午盤股價大跌5.62%

Editas Medicine, Inc.盤中異動早盤快速下跌5.44%

Beam Therapeutics Inc.盤中異動早盤急速拉昇5.07%報32.35美元

Biotech眾生相：藍鳥生物以最高1億美元被收購

国际金融报

因美納全新技術推動多組學研究革新，助力解鎖更深入的生物學見解

Intellia Therapeutics, Inc.盤中異動早盤快速下挫5.00%

Crispr Therapeutics Ag盤中異動股價大跌5.03%報45.50美元

Editas Medicine, Inc.盤中異動早盤急速跳水5.73%報1.81美元

藍鳥生物盤中異動早盤大幅下跌6.00%報3.84美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4556/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因編輯","latestPrice":390.06897,"timestamp":1741205559786,"preClose":386.18573,"halted":0,"volume":15066085,"delay":0,"changeRate":0.010055,"change":3.88324,"pbRate":1.873032,"amount":88453695.625972,"amplitude":0.046291,"prevYearClose":376.62552,"fiveDayClose":408.0821,"twentyDayClose":376.4462,"turnoverRate":0.027603,"marketCap":7246921312,"floatMarketCap":6800519848,"peRate":-3.692897},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":395.95972,"amplitude":0.046291,"preClose":386.18573,"low":378.08292,"pbRate":"1.873032","latestPrice":390.0685,"volume":15066287,"delay":0,"open":386.49673,"prevYearClose":376.62552,"prevWeekClose":396.1103,"prevMonthClose":396.1103,"prevQuarterClose":376.6255,"fiveDayClose":408.0821,"twentyDayClose":376.4462,"sixtyDayClose":408.5231,"secType":"PLATE","market":"US","turnoverRate":0.027603,"peRate":-3.692897,"marketCap":7246921312,"floatMarketCap":6800519848,"timestamp":1741205561818,"nameCN":"基因編輯"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":5,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:16,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514874543","title":"BUZZ-Intellia Therapeutics 第四季度合作收入好於預期，業績大幅增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2514874543","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514874543?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 00:42","pubTimestamp":1740674572,"startTime":"0","endTime":"0","summary":"2月27日 -  ** 总部位于马萨诸塞州的基因编辑公司Intellia Therapeutics NTLA.O股价上涨8.4%，报11.71美元 *  * 根据LSEG汇编的数据，公司第四季度合作收入为1290万美元，高于分析师预计的850万美元。** 公司的销售额主要受Regeneron REGN.O  协议的合作收入推动，该协议旨在开发治疗神经和肌肉疾病的基因编辑疗法。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250227:nL3T3PI1V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2362541273.HKD","SIVBQ","LU2362540622.SGD","LU0289739699.SGD","BK4207","BK4585","LU0823416689.USD","LU2089984988.USD","LU2362541513.USD","LU0320765992.SGD","BK4211","LU1917777945.USD","NTLA","BK4589","BK4556","LU0889565916.HKD","BK4139","LU2023250504.SGD","LU1861558580.USD","LU2468319806.SGD","LU1974910355.USD","LU1861559042.SGD","BK4588","REGN","LU2237438978.USD","LU0114720955.EUR","LU0109394709.USD","LU0058720904.USD","LU2106854487.HKD","LU0053666078.USD","BK4535"],"gpt_icon":0},{"id":"2514384070","title":"Sangamo Therapeutics, Inc.盤中異動 股價大漲5.21%報1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514384070?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:57","pubTimestamp":1740671839,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时57分，Sangamo Therapeutics, Inc.股票出现异动，股价快速上涨5.21%。截至发稿，该股报1.030美元/股，成交量116.742万股，换手率0.56%，振幅6.95%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723572098952223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022723572098952223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","SGMO","LENZ"],"gpt_icon":0},{"id":"2514381222","title":"Crispr Therapeutics Ag盤中異動 股價大漲5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514381222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514381222?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:11","pubTimestamp":1740669085,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时11分，Crispr Therapeutics Ag股票出现异动，股价大幅上涨5.03%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.79%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272311259632ba0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4588","BK4139","LU1861559042.SGD","LENZ","LU1861558580.USD","BK4556","BK4585"],"gpt_icon":0},{"id":"2514385718","title":"Editas Medicine, Inc.盤中異動 早盤大幅上漲5.43%報1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385718","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385718?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:35","pubTimestamp":1740666943,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分，Editas Medicine, Inc.股票出现异动，股价急速上涨5.43%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为431.64%、92.89%、67.22%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.59%、15.14%、14.83%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223543989510d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223543989510d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4139","BK4556"],"gpt_icon":0},{"id":"2514338562","title":"Intellia Therapeutics, Inc.盤中異動 早盤大幅上漲5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514338562?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:32","pubTimestamp":1740666724,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Intellia Therapeutics, Inc.股票出现异动，股价急速上涨5.60%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232059895101f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232059895101f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU1861559042.SGD","BK4139","LU1861558580.USD","NTLA","BK4556","LENZ","BK4588","BK4535"],"gpt_icon":0},{"id":"2514186503","title":"Beam Therapeutics Inc.盤中異動 大幅下跌5.06%報28.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514186503?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 01:57","pubTimestamp":1740592630,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时57分，Beam Therapeutics Inc.股票出现异动，股价急速下挫5.06%。截至发稿，该股报28.33美元/股，成交量52.8583万股，换手率0.63%，振幅5.50%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4535","BK4585","LENZ","BEAM","BK4588","BK4505"],"gpt_icon":0},{"id":"2514043687","title":"Crispr Therapeutics Ag盤中異動 下午盤急速下跌5.00%報44.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514043687?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 03:14","pubTimestamp":1740510850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日03时14分，Crispr Therapeutics Ag股票出现波动，股价急速下跌5.00%。截至发稿，该股报44.24美元/股，成交量135.121万股，换手率1.58%，振幅5.11%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体跌幅为0.16%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022603141096302785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022603141096302785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","CRSP","LU1861558580.USD","LU1861559042.SGD","BK4139","BK4585","LENZ","BK4556"],"gpt_icon":0},{"id":"2514110820","title":"Sangamo Therapeutics, Inc.盤中異動 臨近午盤股價大跌5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514110820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514110820?lang=zh_tw&edition=fundamental","pubTime":"2025-02-26 00:42","pubTimestamp":1740501725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时42分，Sangamo Therapeutics, Inc.股票出现异动，股价大幅下挫5.62%。Sangamo Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Sangamo Therapeutics, Inc.公司简介：Sangamo Therapeutics Inc是一家基因组医学公司，致力于将突破性的科学转化为药物，以改变患有严重神经系统疾病的患者和家庭的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260042069892679d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260042069892679d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4556","SGMO","BK4139"],"gpt_icon":0},{"id":"2514188860","title":"Editas Medicine, Inc.盤中異動 早盤快速下跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514188860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514188860?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 22:31","pubTimestamp":1740493905,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Editas Medicine, Inc.股票出现波动，股价急速下跌5.44%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为748.84%、541.52%、462.86%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Maze Therapeutics, Inc.，振幅分别为62.33%、19.20%、8.87%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223145a25386ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223145a25386ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2514090041","title":"Beam Therapeutics Inc.盤中異動 早盤急速拉昇5.07%報32.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514090041?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 22:31","pubTimestamp":1740493887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时31分，Beam Therapeutics Inc.股票出现异动，股价急速上涨5.07%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Organovo Holdings, Inc.、Moleculin Biotech, Inc.、Silexion Therapeutics Corp涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为747.04%、513.81%、460.17%，振幅较大的相关个股有Organovo Holdings, Inc.、Igm Biosciences, Inc.、Pluri Inc.，振幅分别为18.97%、7.46%、7.15%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223128962ff23e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223128962ff23e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","LENZ","BEAM","BK4505","BK4556","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2514673780","title":"Biotech眾生相：藍鳥生物以最高1億美元被收購","url":"https://stock-news.laohu8.com/highlight/detail?id=2514673780","media":"国际金融报","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514673780?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 19:13","pubTimestamp":1740482032,"startTime":"0","endTime":"0","summary":"上市后，蓝鸟生物股价一路高歌猛进，市值一度逼近300亿美元。截至去年第三季度，蓝鸟生物去年实现营收4528.6万美元，亏损2.12亿美元。果不其然，蓝鸟生物在今年2月宣布“卖身”，但最高1亿美元的价格还是让市场为之震惊。两项合计，此次交易的最高潜在金额约为1亿美元。Biotech众生相在被收购前，蓝鸟生物也曾采取过一系列措施“自救”。其中普方生物的交易金额创下新高，总金额高达130亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCD","BK4578","BK4556","BK4139","BMS","BLUE"],"gpt_icon":0},{"id":"2514503433","title":"因美納全新技術推動多組學研究革新，助力解鎖更深入的生物學見解","url":"https://stock-news.laohu8.com/highlight/detail?id=2514503433","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514503433?lang=zh_tw&edition=fundamental","pubTime":"2025-02-25 12:22","pubTimestamp":1740457320,"startTime":"0","endTime":"0","summary":"基于拥有卓越质量、一致性和准确性的因美纳测序仪，这些新型组学解决方案在规模、准确性和可靠性方面均超越了行业标准。因美纳始终致力于为基因组学突破开辟新路径，现在我们致力于加速多组学各个领域的进展。\" 因美纳首席技术官Steve Barnard博士表示，\"因美纳一如既往地推动开拓性创新并塑造行业标杆。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4626553_ZH26553_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4548","BK4585","LU1861558580.USD","BK4139","CRSP","BK4588","BK4121","ILMN","BK4534","LU1861559042.SGD","BK4535","BK4556"],"gpt_icon":1},{"id":"2514007773","title":"Intellia Therapeutics, Inc.盤中異動 早盤快速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514007773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514007773?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:46","pubTimestamp":1740411993,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时46分，Intellia Therapeutics, Inc.股票出现波动，股价快速跳水5.00%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234633abdb1f9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234633abdb1f9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4588","LU1861559042.SGD","BK4585","BK4535","LENZ","LU1861558580.USD","BK4139","NTLA"],"gpt_icon":0},{"id":"2513772084","title":"Crispr Therapeutics Ag盤中異動 股價大跌5.03%報45.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513772084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513772084?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 23:03","pubTimestamp":1740409397,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，Crispr Therapeutics Ag股票出现波动，股价急速跳水5.03%。截至发稿，该股报45.50美元/股，成交量50.3026万股，换手率0.59%，振幅4.18%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.34%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics AG是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303179890fdaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303179890fdaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4588","BK4585","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4139","LENZ"],"gpt_icon":0},{"id":"2513496720","title":"Editas Medicine, Inc.盤中異動 早盤急速跳水5.73%報1.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513496720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513496720?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:52","pubTimestamp":1740408766,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时52分，Editas Medicine, Inc.股票出现异动，股价快速跳水5.73%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为132.80%、54.81%、25.03%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225246962e9e16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225246962e9e16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2513722444","title":"藍鳥生物盤中異動 早盤大幅下跌6.00%報3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722444?lang=zh_tw&edition=fundamental","pubTime":"2025-02-24 22:33","pubTimestamp":1740407617,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时33分，蓝鸟生物股票出现波动，股价急速下跌6.00%。截至发稿，该股报3.84美元/股，成交量24.78万股，换手率2.54%，振幅2.72%。机构评级方面，在所有7家参与评级的机构中，14%的券商给予买入建议，86%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体跌幅为0.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242233379890f5f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242233379890f5f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4139","BLUE","BK4556"],"gpt_icon":0}],"pageSize":16,"totalPage":3,"pageCount":2,"totalSize":45}]}}